Clinical trial
Randomised Trial of Tenecteplase vs. Alteplase for Recanalisation in Acute Ischemic Stroke
NCT01949948 is registered in ClinicalTrials.gov with Lars Thomassen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Trial of Tenecteplase vs. Alteplase for Recanalisation in Acute Ischemic Stroke
- Lead sponsor
- Lars Thomassen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- December 31, 2016
- Enrollment
- 1,050 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.